Navigating the PrEP Landscape – PrEPWatch is here to help!

Dear Advocate,

With a growing number of PrEP products in development and approved for use in various countries, and an increase in PrEP initiations worldwide, the future of PrEP has never been more exciting. Check out our newly redesigned PrEPWatch website to help navigate the latest research, policy developments, implementation strategies, and advocacy efforts worldwide. The updated site features an array of expanded PrEP resources and improved navigation. We hope PrEPWatch and its resources will be helpful in your advocacy.

Explore the Latest on PrEPWatch

Enhanced Resource Library

An extensive collection of updated tools, research, and guidelines, making it easier than ever for users to access the latest information on PrEP implementation and best practices. Check out some of the most used resources like the Integrated Study Dashboard.

Interactive Global PrEP Tracker

Provides up-to-date information on PrEP initiations by country and delivery model, offering insights into the progress and impact of PrEP programs around the world.

Country Planning Tracker

Navigable matrix showing where PrEP products are currently approved and where approval is pending. It also tracks key indicators for the introduction of new PrEP options by country, including late-stage clinical trials and implementation research, procurement plans, and more.

CAB for PrEP Evidence Tracker

Summarizes the latest insights from the Biomedical Prevention Implementation Collaborative (BioPIC) on injectable CAB for PrEP, links to learn more, and information on where evidence is still needed, mapped against priority evidence gaps.

Updated Product Pages

Updated product information addressing frequently asked questions about PrEP options that are currently available and those in late-stage clinical development – including updates on the latest news related to injectable lenacapavir.

Long-Acting PrEP Status Update

Quarterly dashboard produced on behalf of the Coalition to Accelerate Access to Long-Acting PrEP with graphics on regulatory approvals, volumes, ongoing and planned implementation science studies, and non-profit prices for currently available long-acting PrEP products.

The resources on PrEPWatch come from projects and partners from around the world; if you have information to share or resource needs, please email [email protected]. And we are grateful for support to AVAC from the Gates Foundation via BioPIC and from PEPFAR via USAID and the Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC) project that makes PrEPWatch possible.

Best,

AVAC

P.S. Be sure to join us Monday, August 5, for our TCA webinar, Including People with Disabilities in HIV Prevention Programming and Research.

Share this issue

You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences | Unsubscribe